Literature DB >> 8179010

Inhibiting gastric H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and production of parietal cells.

S M Karam1, J G Forte.   

Abstract

Parietal cell morphology was studied after chronic inhibition of gastric H(+)-K(+)-adenosinetriphosphatase (ATPase) by omeprazole. Gastric mucosa from rabbits treated with omeprazole every 12 h (1 mg/kg sc) for 5 days were compared with sham-injected animals using immunohistochemistry and electron microscopy. Three immunocytochemical markers, including antibodies against the alpha- and beta-subunits of the H(+)-K(+)-ATPase, showed that some parietal cells in omeprazole-treated rabbits displayed light areas and granularity in their cytoplasm. These abnormalities were also apparent in semithin sections. Electron microscopy was used to categorize and quantitate the specific structural abnormalities in parietal cells. Cells were classified as normal, altered, or degenerated. For control tissues, altered and degenerated parietal cells were few; they collectively represented 6% of total parietal cells and were located mainly deep in the gland base. For omeprazole-treated tissues, altered and degenerated parietal cells occurred throughout the gland and averaged 62% of total parietal cells. In addition, macrophages invaded the mucosa presumably to eliminate degenerated cells. Although there was an increase in parietal cell degeneration, enhanced parietal cell generation was suggested by increases in mitosis among proliferative cells and, more specifically, in the number of preparietal cells. After 3 days of recovery from the omeprazole regimen, parietal cells and the gastric mucosa appeared to recover the normal morphology. In conclusion, blocking H(+)-K(+)-ATPase by omeprazole enhances degeneration and macrophage-mediated elimination of parietal cells and also causes an increase in preparietal cell production. Thus omeprazole temporarily changes the dynamic features of parietal cells in the rabbit to make them die early and grow fast.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179010     DOI: 10.1152/ajpgi.1994.266.4.G745

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  KCNQ1 is the luminal K+ recycling channel during stimulation of gastric acid secretion.

Authors:  Penghong Song; Stephanie Groos; Brigitte Riederer; Zhe Feng; Anja Krabbenhöft; Adam Smolka; Ursula Seidler
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

2.  Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients.

Authors:  A Tari; M Hamada; T Kamiyasu; K Sumii; K Haruma; M Inoue; S Kishimoto; G Kajiyama; J H Walsh
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

3.  Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.

Authors:  D K Driman; C Wright; G Tougas; R H Riddell
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

4.  Effects of streptozotocin-induced long-term diabetes on parietal cell function and morphology in rats.

Authors:  Salim M A Bastaki; Ernest Adeghate; Irwin S Chandranath; Naheed Amir; Saeed Tariq; Rashed S Hameed; Abdu Adem
Journal:  Mol Cell Biochem       Date:  2010-03-17       Impact factor: 3.396

5.  Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.

Authors:  Jonathan E Kohler; Amy L Blass; Jingjing Liu; Kaniza Tai; David I Soybel
Journal:  Free Radic Biol Med       Date:  2010-06-08       Impact factor: 7.376

6.  Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.

Authors:  A Tari; M Hamada; T Kamiyasu; Y Fukino; M Sumii; K Haruma; K Sumii; M Inoue; G Kajiyama
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

7.  Gastritis and hypergastrinemia due to Acinetobacter lwoffii in mice.

Authors:  Y Zavros; G Rieder; Amy Ferguson; J L Merchant
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 8.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors.

Authors:  S M Karam; C Tomasetto; M-C Rio
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

10.  Epithelial cell expression of BCL-2 family proteins predicts mechanisms that regulate Helicobacter pylori-induced pathology in the mouse stomach.

Authors:  Susan J Hagen; David X Yang; Kimihito Tashima; Nancy S Taylor; James G Fox
Journal:  Lab Invest       Date:  2008-09-08       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.